The Antidepressant Dilemma: Who Are You Without Your Pills?

One in six American adults currently takes antidepressants. But here's the question keeping many of them awake at night: Who would I be without these pills?

A reader's anonymous letter to advice columnist Sigal Samuel captures this modern dilemma perfectly. After years on medication since their late teens, they're now wondering if they're "medicating unnecessarily" and whether they owe it to themselves to discover their "true self" off the drugs.

It's a question that cuts to the heart of 21st-century identity—and reveals how little we still understand about both depression and the drugs we use to treat it.

The Science We Don't Have

The uncomfortable truth is that we still don't really know how antidepressants work. The old "chemical imbalance" theory—the idea that depression stems from insufficient serotonin in the brain—has been largely debunked by modern neuroscience. Today's leading hypothesis involves neuroplasticity, but even that remains largely theoretical.

What we do know is that antidepressants are 25% more effective than placebos on average. But that "on average" carries enormous weight—effectiveness varies dramatically from person to person, and the pharmaceutical industry has done shockingly little research on how to safely wean people off these medications.

Dr. Awais Aftab, a psychiatrist, points out the cruel irony: while long-term users wonder who they'd be without medication, unmedicated individuals often wonder who they could become with it. "Could I be more functional, more productive, a better parent?" they ask themselves.

The Philosophy of Pharmaceutical Identity

This isn't just a medical question—it's a profound philosophical one. When medications shape our thoughts and emotions, they're essentially reshaping what we consider to be our "self." And that raises uncomfortable questions about authenticity and identity that most 20-minute psychiatric appointments simply can't address.

Anthropologist Alice Malpass offers a useful framework: managing antidepressants involves both a "medication career" (practical decisions about dosage and duration) and a "moral career" (the meaning we assign to those decisions). The moral dimension, she argues, is equally important because the stories we tell ourselves about our medications directly impact treatment outcomes.

But here's where Samuel's advice takes an unexpected turn: she argues there is no "true self" to betray or discover. Instead of one fixed essence, we're constantly being shaped by everything around us—family, media, coffee, yoga, and yes, medication.

The Kierkegaard Solution

Drawing on 19th-century philosopher Søren Kierkegaard, Samuel suggests we stop looking backward for some mythical authentic self and instead look forward to who we want to become. "Life can only be understood backwards," Kierkegaard observed, "but it must be lived forwards."

This reframes the entire dilemma. Instead of asking "Who am I really?" the question becomes "Who do I want to be?" And that's a choice we make based on available information, not some predetermined destiny we're supposed to discover.

Harry Frankfurt's distinction between first-order desires (what we want) and second-order desires (what we want to want) adds another layer. True autonomy isn't about being free from all dependencies—it's about having your desires aligned. If you want to be the kind of person who's present, kind, and creative, and medication helps you achieve that, then taking it aligns with your deeper values.

The Global Context

This philosophical wrestling match is playing out differently across cultures. While Western philosophy has long emphasized individual authenticity and the "true self," Japanese philosophy offers a more fluid understanding of identity. The Western obsession with fixed selfhood, some argue, has created unnecessary ethical confusion about pharmaceutical intervention.

Meanwhile, the practical realities vary dramatically. In countries with universal healthcare, the decision-making process looks different than in the U.S., where insurance coverage and cost considerations add another layer of complexity to an already difficult choice.

The Withdrawal Reality

The conversation is further complicated by the reality of antidepressant withdrawal. While these medications don't create "addiction" in the technical sense (they don't involve compulsiveness or escalating doses despite harm), physical dependence is real. Some people experience severe withdrawal symptoms when stopping, which has led to legitimate concerns about informed consent when starting these medications.

The psychiatric establishment's failure to adequately study withdrawal protocols represents a significant ethical failure. Patients are essentially flying blind when trying to discontinue medications they may have been taking for decades.